News | May 06, 2011

Advanced 3-D Mapping, Ablation Force Control Integrated to Treat Arrhythmias

May 6, 2011 – Rhythmia Medical Inc. and Endosense have engaged in a joint development project to integrate the contact-force data provided by Endosense’s TactiCath force-sensing ablation catheter into Rhythmia’s advanced three-dimensional cardiac mapping, visualization and navigation system. The project’s objective is to build on earlier feasibility tests to develop an integrated solution that allows electrophysiologists to quickly, efficiently and effectively view catheter tip-to-tissue contact force on a high-resolution, 3-D electro-anatomical map.

The joint development project brings together two recognized innovators in the catheter ablation treatment of cardiac arrhythmias. Rhythmia Medical is pioneering new technology to allow for fast, simple and accurate 3-D mapping of electrical heart activity. Endosense pioneered the field of contact-force sensing with its TactiCath force-sensing ablation catheter and accompanying TactiSys system. By integrating their technologies, Rhythmia Medical and Endosense intend to provide electrophysiologists with an exceptional user experience to improve the patient outcomes of cardiac ablation procedures.

“By building Endosense’s contact-force sensing capability into Rhythmia Medical’s open platform advanced 3-D mapping, visualization and navigation system, we have the potential to deliver a new solution that will enhance the value of 3-D mapping with the greater insight and control of force-sensing into the EP lab,” said Leon Amariglio, co-chief executive officer of Rhythmia. “We are excited to be partnering with an industry leader and pioneer like Endosense to bring these significant benefits to electrophysiologists and their patients.”

Eric Le Royer, chief executive officer, Endosense, also commented on the development project. “We expect our joint effort with Rhythmia to yield a compelling new tool for electrophysiologists, as it will marry two very complementary, state-of-the-art technologies aimed at improving the efficacy, safety and ease of performing cardiac ablation procedures. I have witnessed the benefits of the speed, accuracy and ease of use of the Rhythmia system during the earlier pre-clinical feasibility tests we conducted together. We are happy to partner with this innovative company as part of our open platform strategy to integrate value-added contact-force sensing capability into advanced 3-D mapping systems.”

Endosense is also executing an open platform strategy to integrate its technology into a range of three-dimensional cardiac mapping systems. Biotronik is the exclusive distributor of the TactiCath in Europe, Latin America, Canada, Africa and the Middle East. The system is not yet cleared for use in the United States.

For more information:,

Related Content

Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Overlay Init